Hyperparathyroidism 2

Common Name(s)

Hyperparathyroidism 2

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hyperparathyroidism 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hyperparathyroidism 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hyperparathyroidism 2" returned 5 free, full-text research articles on human participants. First 3 results:

Giant primary synchronously bilateral mesenteric dedifferentiated liposarcoma with hyperparathyroidism, hyperthyroidism, type-2 diabetes mellitus and hypertension.
 

Author(s): Birol Korukluoglu, Emre Ergul, Ibrahim Cagatay Sisman, Samet Yalcin, Ahmet Kusdemir

Journal: J Pak Med Assoc. 2009 Aug;59(8):563-5.

 

Liposarcomas represent the single most common type of soft tissue sarcoma, occurring most commonly in the extremities and retroperitoneum. There is no relation between liposarcomas and multiple endocrine syndromes. We presented a 61-year old woman with giant primary synchronously ...

Last Updated: 17 Sep 2009

Go To URL
The association of primary hyperparathyroidism and primary ovarian failure: a de novo t(X; 2) (q22p13) reciprocal translocation.
 

Author(s): Gul Bano, Sahar Mansour, Stephen Nussey

Journal: Eur. J. Endocrinol.. 2008 Feb;158(2):261-3.

 

A 40-year-old female presented with primary amenorrhoea at 17 years of age. She was tall at 98th centile for height with eunuchoidal body habitus. Her breast development was Tanner stage 3, pubic and axillary hair Tanner stage 4 with normal external genitalia. Her bone age was 13.4 ...

Last Updated: 30 Jan 2008

Go To URL
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
 

Author(s): Eduardo Slatopolsky, Jane L Finch, Alex J Brown, Cynthia S Ritter, Masahide Mizobuchi, Lori A Plum, Margaret Clagett-Dame, Rafal R Sicinski, Hector F DeLuca

Journal: J. Bone Miner. Res.. 2007 May;22(5):686-94.

 

Vitamin D analogs are being developed that retain therapeutic effects but are less calcemic and phosphatemic, a concern in CKD patients who are prone to vascular calcification. We tested a new analog of vitamin D, 2MbisP, and found that it suppresses PTH at doses that do not affect serum Ca or P.

Last Updated: 20 Apr 2007

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hyperparathyroidism 2" returned 1 free, full-text review articles on human participants. First 3 results:

Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.
 

Author(s): Nobuo Nagano, Edward F Nemeth

Journal: J. Pharmacol. Sci.. 2005 Mar;97(3):355-60.

 

Circulating levels of calcium ion (Ca(2+)) are maintained within a narrow physiological range mainly by the action of parathyroid hormone (PTH) secreted from parathyroid cells. Parathyroid cells can sense small fluctuations in plasma Ca(2+) levels by virtue of a cell surface Ca(2+) ...

Last Updated: 23 Mar 2005

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Single-dose Study in Paediatric Subjects Aged 2 to Less Than 18 Years With (sHPT) Receiving Haemodialysis
 

Status: Not yet recruiting

Condition Summary: Chronic Kidney Disease, Secondary Hyperparathyroidism

 

Last Updated: 12 Jul 2016

Go to URL